Variation in the glycoprotein and VP35 genes of Marburg virus strains

Virology

Volumn 240, Issue 1, 1998, Pages 138-146

  Sanchez, Anthony ^a   Trappier, Sam G ^a   Ströher, Ute ^b   Nichol, Stuart T ^a   Bowen, Michael D ^a   Feldmann, Heinz ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYBRID PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CORONAVIRUS; EBOLA VIRUS; FILOVIRIDAE; GENETIC VARIABILITY; INFLUENZA VIRUS; MARBURG VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARAMYXOVIRUS; PRIORITY JOURNAL; RETROVIRUS; VIRUS HEMORRHAGIC FEVER;

CORONAVIRUS; DARWINIA; EBOLA VIRUS; FILOVIRIDAE; INFLUENZA VIRUS; LAKE VICTORIA MARBURGVIRUS; PARAMYXOVIRIDAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032484488     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8902     Document Type: Article

References (33)

1. Bukreyev A. A., Volchkov V. E., Blinov V. M., Dryga S. A., Netesov S. V. The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: A comparison with the Musoke (1980) strain. Arch. Virol. 140:1995;1589-1600.
2. Centers for Disease Control and Prevention and National Institutes of Health, 1993, Biosafety in Microbiological and Biomedical Laboratories, U. S. Department of Health and Human Services.
3. Chambers P., Pringle C. R., Easton A. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
4. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
5. Endo T, Ikeo K., Gojobori T. Large-scale search for genes on which positive selection may operate. Mol. Biol. Evol. 13:1996;685-690.
6. Feldmann H., Will C., Schikore M., Slenczka W., Klenk H.-D. Glycosylation and oligomerization of the spike protein of Marburg virus. Virology. 182:1991;353-356.
7. Feldmann H., Mühlberger E., Randolf A., Will C., Kiley M. P., Sanchez A., Klenk H.-D. Marburg virus, a filovirus: Messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 24:1992;1-19.
8. Feldmann H., Nichol S. T., Klenk H.-D., Peters C. J., Sanchez A. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology. 199:1994;469-473.
9. Feldmann H., Klenk H.-D. Marburg and Ebola viruses. Adv. Virus Res. 47:1996;1-52.
10. Felsenstein, J. 1993, PHYLIP: Phylogeny Inference Package, University of Washington, Seattle, WA.
11. Fitch W. M., Leiter J. M. EJ. M., Li X., Palese P. Positive Darwinian evolution in human influenza A viruses. Proc. Natl. Acad. Sci. USA. 88:1991;4270-4274.
12. Gallaher W. R. Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell. 85:1996;477-478.
13. Gear J. S. S., Cassel G. A., Gear A. J., Trappler B., Clausen L., Meyers A. M., Kew M. C., Bothwell T. H., Sher R., Miller G. B., Schneider J., Koornhof H. J., Gomperts E. D., Isaäcson M., Gear J. H. S. Outbreak of Marburg virus disease in Johannesburg. Br. Med. J. 4:1975;489-493.
14. Geisbert T. W., Jahrling P. B. Differentiation of filoviruses by electron microscopy. Virus Res. 39:1996;129-150.
15. Georges-Courbot M.-C., Sanchez A., Lu C.-Y., Baize S., Leroy E., Lansout-Soukate J., T'nissan Georges A. J., Trappier S. G., Zaki S. R., Swanepoel R., Leman P. A., Rollin P. E., Peters C. J., Nichol S. T., Ksiazek T. G. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg. Inf. Dis. 3:1997;59-62.
16. Jarhling P. B., Kiley M. P., Klenk H.-D., Peters C. J., Sanchez A., Swanepoel R. Family Filoviridae. Arch. Virol. 10:1995;289-292.
17. Johnson E. D., Kohnson B. K., Silverstein D., Tukei P., Geisbert T. W., Sanchez A., Jahrling P. B. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. 11:1997;101-114.
18. Kiley M. P., Cox N. J., Elliott L. H., Sanchez A., DeFries R., Buchmeier M. J., Richman D. D., McCormick J. B. Physicochemical properties of Marburg virus: Evidence for three distinct virus strains and their relationship to Ebola virus. J. Gen. Virol. 69:1988;1957-1967.
19. Ksiazek T. G., Rollin P. E., Jahrling P. B., Johnson E., Dalgard D. W., Peters C. J. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J. Clin. Microbiol. 30:1992;947-950.
20. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Petteway S. R. Jr. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
21. Peters C. J., Johnson E. D., Jahrling P. B., Ksiazek T. G., Rollin P. E., White J., Hall W., Trotter R., Jaax N. Filoviruses. Morse S. Emerging Viruses. 1993;159-175 Oxford Univ. Press, New York.
22. Peters, C. J. Sanchez, A. Rollin, P. E. Ksiazek, T. G. Murphy, F. A. 1996, Filoviridae: Marburg and Ebola viruses, In, Fields Virology, B. N. FieldsD. M. KnipeP. M. Howleyet al, 1, 1161, 1176, Lippincott-Raven Press, Philadelphia.
23. Sanchez A., Kiley M. P. Identification and analysis of Ebola virus messenger RNA. Virology. 157:1987;414-420.
24. Sanchez A., Kiley M. P., Holloway B. P., McCormick J. B., Auperin D. D. The nucleoprotein gene of Ebola virus: Cloning, sequencing and in vitro expression. Virology. 170:1989;81-91.
25. Sanchez A., Kiley M. P., Holloway B. P., Auperin D. D. Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res. 29:1993;215-240.
26. Sanchez A., Trappier S. G., Mahy B. W. J., Peters C. J., Nichol S. T. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. USA. 93:1996;3602-3607.
27. Siegert R., Shu H.-L., Slenczka W., Peters D., Müller G. Zur Äthiologie einer unbekannten von Affen ausgegangenen Infektionskrankheit. Dtsch. Med. Wochenschr. 92:1967;2341-2343.
28. Smith D. H., Johnson B. K., Isaäcson M., Swanapoel R., Johnson K. M., Bagshawe A., Siongok T., Keruga W. K. Marburg-virus disease in Kenya. Lancet. 1:1982;816-820.
29. Volchkov V. E., Blinov V. M., Netesov S. V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305:1992;181-184.
30. Volchkov V. E., Becker S., Volchkova V. A., Ternovoj V. A., Kotov A. N., Netesov S. V., Klenk H.-D. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology. 214:1995;421-430.
31. Volchkov V. E., Volchkova V., Eckel C., Klenk H.-D., Bouloy M., LeGuenno B., Feldmann H. Emergence of subtype Zaire Ebola virus in Gabon. Virology. 232:1997;139-144.
32. Will C., Mühlberger E., Linder D., Slenczka W., Klenk H.-D., Feldmann H. Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J. Virol. 67:1993;1203-1210.
33. Yamaguchi Y., Gojobori T. Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA. 94:1997;1264-1269.